SYNOPSIS Samples of maternal and foetal blood and of human milk, cow's milk, and dried cow's milk have been analysed for cobalamins by chromatography and bioautography. Plasma cobalamins in late pregnancy and after delivery differed quantitatively from those in healthy non-pregnant women. Differences in the proportions of plasma cobalamins were also observed between mothers and their newborn infants. The findings suggest that methylcobalamin may be a more labile plasma form of the vitamin than 5-deoxyadenosyl cobalamin. Breast milk from healthy mothers contained more deoxyadenosylcobalamin and proportionately less methylcobalamin than their plasma. Cyanocobalamin given parenterally to lactating women was detected in the plasma, and high concentrations appeared unchanged in the milk. The B12 in fresh cow's milk was found to be largely 5-deoxyadenosyl cobalamin whereas dried milk contained only hydroxocobalamin and a little cyanocobalamin. The nutritional implications of the findings, and their bearing on problems of cobalamin transport, are discussed.
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Relatively little is known about the role of vitamin B12 in the developing foetus and the mechanisms by which it acquires this vitamin from the mother. Early animal studies (O'Dell, Whitley, and Hogan, 1951; Grainger, O'Dell, and Hogan, 1954) showed that B12 deficiency in the mother is frequently associated with hydrocephalus and other congenital abnormalities in the offspring. In man, it has been observed that patients with pernicious anaemia may be infertile (Adams, 1958; Sharp and Witts, 1962; Jackson, Doig, and McDonald, 1967) , and even when conception occurs, a normal pregnancy rarely ensues without some form of B12 supplementation.
Vitamin B12 is required increasingly by the foetus as development proceeds. Cobalamins are supplied via the placenta from the maternal circulation (Boger, Wright, Beck, and Bayne, 1956; Ball and Giles, 1964) , whose total of B12 may temporarily fall to a level well below that found in healthy non-pregnant women. The newborn infant, whether breast or bottle-fed, obtains its B12 from the milk. Many workers have estimated total B12 in milk and in maternal and foetal blood (Karlin and Dumont, 1955; Baker, Ziffer, Pasha, and Zobotka, 1958; Baker, Jacob, Rajan, and Swaminathan, 1962) . Nothing is known, however, about the individual cobalamins making up the total B12 of foetal blood or milk, and knowledge concerning the The development of a sensitive bioautographic method for the separate estimation of cobalamins (Linnell, Mackenzie, and Matthews, 1969a; Linnell, Mackenzie, Wilson, and Matthews, 1969b) has enabled us to carry out the present study of the plasma cobalamins in healthy non-pregnant women, and in women near term, following delivery and in the puerperium. In the last group, cobalamins were estimated in breast milk before and after systemic B12 administration. In addition, cobalamins were estimated in samples of liquor amnii and in the plasma of newborn infants.
Material and Methods
Heparinized blood (10 ml) was taken from 12 healthy non-pregnant women of childbearing age for the estimation of total B12 and plasma cobalamins. In four patients approaching term samples of liquor amnii were collected and venous blood was taken at the same time. In a further four subjects peripheral and cord blood was sampled at delivery. Breast milk (10 ml) was collected from 10 mothers four to eight days after delivery when lactation was well established and venous blood was drawn simultaneously. In order to study the transfer of cobalamins into breast milk, two volunteers were given intramuscular 449 cyanocobalamin, 100 (Matthews, Gunasegaram, and Linnell, 1967) . The Euglena method (Hutner, Bach, and Ross, 1956 ) was used for the assay of total B12 in milk since it was found that the high fat content interfered with binding in the radioisotopic method. Individual cobalamins were estimated by the chromato-bioautographic method I. L. Craft, D. M. Matthews, and J. C. Linnell previously described (Linnell et al, 1969a,b) . Deoxyadenosylcobalamin was not routinely separable from hydroxocobalamin in this study and is referred to as Co-OH B12. However, a method for separating deoxyadenosylcobalamin from hydroxocobalamin has subsequently been developed (Linnell, Hussein, and Matthews, 1970) and has permitted the separate estimation of these two cobalamins in one or two cases.
Results
Total plasma B12 and plasma cobalamins in 12 healthy non-pregnant women are shown in Table I ; the values fall within the normal range published previously (Linnell et al, 1969a) . The separate estimation of hydroxocobalamin was undertaken in two subjects and the results indicated that approximately 10% of the plasma total B12 was present in this form.
Plasma cobalamins in eight subjects at or approaching delivery are shown in Table II plasma total B12 (mean 307 pg/ml) was less than that in controls (mean 413 pg/ml) but the difference was not significant. However, the methylcobalamin levels (mean 189 pg/ml) were considerably lower than the control values (mean 277 pg/ml), the difference being statistically significant.
Results in the group of lactating mothers are seen in Table III , and a chromato-bioautogram from the milk and plasma of one subject is shown in Figure  1 . The plasma total B12 (mean 490 ± 56 pg/ml) was not significantly different from that of the controls although the Me/Co-OH ratio was slightly raised (this difference was not quite significant at the 5% level). A comparison of both total B12 and Me/Co-OH ratio in the full-term and lactating women revealed highly significant differences between the groups. Total B12 in the milk from seven of the 10 mothers was higher than the plasma level but as a group (mean 605 ± 185 pg/ml) this increase was not significant since individual values varied widely. The proportion of Co-OH B12 was markedly higher in milk than plasma and a statistical comparison of the Me/Co-OH ratios showed the difference to be highly significant (p < 0-001). Separation of cobalamins in three milk samples using the second solvent system indicated that the proportion of hydroxocobalamin was less than 5 % of the total milk B12.
Information concerning the transfer of cobalamins into breast milk was obtained following the parenteral administration of cyanocobalamin. Figure 2 shows that the rise in cyanocobalamin in the milk was greater than that in the plasma at either dosage and accounted for much of the increase in total B12. Figure 3 . Total B1, in cord blood was 50%-100% above the maternal level, and the proportion of methylcobalamin also was slightly but consistently higher. Small amounts of cyanocobalamin were detected in blood from three of the four mothers and their respective infants but levels were within the normal range. In three of the subjects samples from the umbilical artery were assayed alongside those from the umbilical vein, but no significant difference was observed in either total B1, or plasma cobalamins.
Results in the four samples of amniotic fluid revealed no consistent pattern. In two the total B12 (205, 145 pg/ml) was similar to the plasma level (210, 190 pg/ml). The third specimen had a high B12 concentration (1,160 pg/ml), five times that of the plasma, while in the fourth the total B12 was low (10 pg/ml) although the plasma level was quite normal (300 pg/ml). Chromatographically, a single spot corresponding to Co-OH B12 was detected in the two samples with the higher total B12 but in the two remaining specimens no cobalamins were detected even when loading of the chromatogram was increased. These results appear similar to the chromatographic findings in normal urine (unpublished) where the B12 is almost certainly present as hydroxocobalamin.
Parameter
Groups Compared" approximately one-sixth the mean value of the powdered milks. Chromatography was carried out on product no. 1; Co-OH B12 and a little cyanocobalamin were detected. Since the products were exposed to light during processing and again in preparing feeds it may be assumed that the major portion of the total B12 was present as hydroxocobalamin. Chromatography of two samples of fresh cow's milk revealed the presence of a single spot with the Rf of Co-OH B12. Neither methylcobalamin nor cyanocobalamin was detected.
Discussion
Changes in total serum BL, during pregnancy and in the puerperium have been thoroughly studied by many workers (Karlin and Dumont, 1955; Boger et al, 1956b; Boger, Wright, and Bayne, 1957; Izak, Rachmilewitz, Stein, Berkovici, Sadovsky, Arnovitch, and Grossovicz, 1957; Baker et al, 1958; Baker et al, 1962; Low-Beer, McCarthy, Austad, Brzechwa-Ajdukiewicz, and Read, 1968; Hibberd and Spencer, 1970; Jathar, Kamath, Parikh, Rege, and Satoskar, 1970) . The normal picture is of a slowly declining blood level, steepening somewhat towards term but rising again rapidly and spontaneously after delivery. Our results accord with this pattern and show the difference in total plasma B1, between full-term and lactating groups to be highly significant. Concurrent with this change is an alteration in the proportion of the plasma cobalamins making up the total B12, Before term there is placental transfer of the vitamin to the foetus and, compared with the mother, there is a raised level of methylcobalamin in the foetal plasma. Following delivery lactation commences, and a mixture of cobalamins appears in the breast milk in which the proportion of methylcobalamin is lower than that in the mother's plasma. Together these observations may explain the postpartum rise in maternal plasma Me/Co-OH ratio. Previous evidence (Linnell et al. I. L. Craft, D. M. Matthews, and J. C. Linnell 1969b, Linnell, Hoffbrand, Peters, and suggests that methylcobalamin may be a more labile plasma component than deoxyadenosylcobalamin, a contention which is supported by the present findings. Rappazzo, Salmi, and Hall (1970) found the total B12 of various foetal tissues, including bone marrow, spleen, and thyroid, to be significantly higher than that of identical adult tissues. The foetus receives its B12 via the placenta but the reasons for the higher total B12 and the raised proportion of methylcobalamin in foetal plasma are not clear. Active transport processes or binding phenomena could be responsible. Flodh (1968) has suggested that B12 may be transferred to the foetus as methylcobalamin. Kumento, Lopez, Luhby, and Hall (1967) The newborn infant is dependent on the milk to meet its continued B12 requirement. The present results in breast milk sampled four to eight days after delivery show that the increase in Co-OH B12 largely accounts for the rise in total milk B12 above the plasma level. Whether this alteration is due to interconversion of cobalamins or to preferential binding of deoxyadenosylcobalamin by the milk is not known. Metz, Zalusky, and Herbert (1968) found that breast milk contained a potent binder for folate and that orally administered folic acid attained considerably higher levels in breast milk than in the serum, albeit after a delay of some hours. Studies on the B12-binding capacity of milk from different species (Glass, 1963) indicate, however, that total B12 correlates poorly with binding capacity (eg, cow's milk, total B12 approximately 3,000 pg/ml, B12 BC 5,000 pg/ml; breast milk, total B12 approximately 600 pg/ml, B12 BC 80,000 pg/ml). The possibility that interconversion of cobalamins takes place during membrane transport is shown by the finding that cyanocobalamin is partly converted to deoxyadenosylcobalamin during intestinal absorption . Some cyanocobalamin, however, escapes conversion, appearing as such in the peripheral blood ). The present experiments show that unchanged cyanocobalamin can also pass from blood to milk. The mother's B12 intake is normally adequate both for herself and her child and the maternal plasma total B12 declines only after prolonged lactation (Shapiro, Alberts, Welch, and Metz, 1965) . The total B12 concentration of the milk falls progressively, but this is compensated by the mother's increasing milk output. Karlin (1954) recorded mean values from two mothers which showed a decline of 400 pg B12 per millilitre milk in a period of eight months but the average daily milk output rose by over 400 g in the same time. The breast-fed baby receives a mixture of B12 coenzymes in which deoxyadenosylcobalamin may predominate. The child reared by bottle obtains its B12 largely as hydroxocobalamin, although generally at higher concentration. Hence an infant of 1 to 2 weeks taking some 800 ml milk a day would obtain perhaps 0-5 ,tg B12 if breast fed against a daily 2 5 ,tg from modified cow's milk. Were the total B12 intake considered alone it might appear that the breast-fed child was at a disadvantage by comparison with its bottle-fed contemporary. However, the significance of the high coenzyme levels in breast milk may be to furnish the infant with a form of the vitamin immediately usable by the actively growing tissues. It is known that the newborn are deficient in many enzyme systems, which develop only slowly over the first few weeks or months of life. Little is known of the B12-dependent enzyme systems at this time but it may be assumed from the progress made by the majority of bottle-fed children that an ability to utilize hydroxocobalamin normally exists from the earliest age. Children suffering from a rare inborn error of B12 metabolism, however, may not be so capable of handling hydroxocobalamin or cyanocobalamin. Such a case was described recently Abeles, 1969, Levy, Mudd, Schulman, Dreyfus, and Abeles, 1970) where a 4-week-old child presented with a combined homocystinuria/methylmalonic aciduria which was exacerbated by parenteral cyanocobalamin. The infant died at 71 weeks. Postmortem studies revealed abnormally low levels of deoxyadenosylcobalamin in both liver and kidney coexisting with a deficiency of methyltetrahydrofolate methyltransferase. While it is unlikely that a child with such manifold biochemical lesions could survive, had breast-feeding been employed it may well be that the deficiency in cobalamin coenzymes might, at least in part, have been remedied. This work was supported by grants from the Wellcome Trust and Glaxo Laboratories Limited. We are most grateful to Dr R. J. Wrighton for providing certain samples and much helpful information. Our sincere thanks are due to the volunteers who participated in this study, to Miss Heather Mackenzie and Mr H. A-A. Hussein for skilled technical assistance, and to Mr P. W. Pramod for so ably undertaking the Euglena B12 assay.
